At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
HLVX HilleVax, Inc.
Halted 09-16 16:00:00 EDT
2.09
+0.00
0.00%
High2.09Low2.09Vol0.00
Open2.09D1 Closing2.09Amplitude0.00%
Mkt Cap104.79MTradable Cap58.63MTotal Shares50.14M
T/O5.86MT/O Rate0.00%Tradable Shares28.05M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Rpt-Trump: Cdc Vaccine Committee Made a Very Good Decision to End Their Hepatitis B Vaccine Recommendation for Babies
THOMSON REUTERS  ·  12-06
Rpt-Trump: Cdc Vaccine Committee Made a Very Good Decision to End Their Hepatitis B Vaccine Recommendation for Babies
XOMA Royalty reports Q3 revenue of $9.4 million and year-to-date revenue of $38.4 million
Reuters  ·  11-12
XOMA Royalty reports Q3 revenue of $9.4 million and year-to-date revenue of $38.4 million
XOMA Royalty Corporation Completes Acquisition of HilleVax, Inc
Reuters  ·  09-24
XOMA Royalty Corporation Completes Acquisition of HilleVax, Inc
Xoma announces closing of tender offer for HilleVax
TIPRANKS  ·  09-17
Xoma announces closing of tender offer for HilleVax
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.
GlobeNewswire  ·  09-17
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.
XOMA Royalty Corporation Reports Q2 2025 Net Income of $9.2M, Cash Receipts Rise to $11.7M
Reuters  ·  08-13
XOMA Royalty Corporation Reports Q2 2025 Net Income of $9.2M, Cash Receipts Rise to $11.7M
HilleVax Q2 EPS $(0.23) Misses $(0.20) Estimate
Benzinga  ·  08-07
HilleVax Q2 EPS $(0.23) Misses $(0.20) Estimate
HilleVax Inc. Announces Agreement to Be Acquired by XOMA Royalty for $1.95 Per Share Plus Contingent Value Right
Reuters  ·  08-04
HilleVax Inc. Announces Agreement to Be Acquired by XOMA Royalty for $1.95 Per Share Plus Contingent Value Right
Hillevax Enters Into a Definitive Agreement to Be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right
THOMSON REUTERS  ·  08-04
Hillevax Enters Into a Definitive Agreement to Be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right
Hillevax Inc. Conducted Annual Stockholder Meeting
Reuters  ·  06-26
Hillevax Inc. Conducted Annual Stockholder Meeting

Introduction

Company Name.
HilleVax, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.
Issue price:
--